James L Ferrara, MD
img_James L Ferrara
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Pediatrics
PROFESSOR | Oncological Sciences
Research Topics
Cytokines, Immunological Tolerance, Immunology, Inflammation, Stem Cells, Transplantation
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]

Selected Publications

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis. Yu Akahoshi, Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K. Choe, Matthias Eder, Aaron M. Etra, Stephan A. Grupp, Elizabeth O. Hexner, William J. Hogan, Carrie L. Kitko, Sabrina Kraus, Monzr M. Al Malki, Pietro Merli, Muna Qayed, Ran Reshef, Tal Schechter, Evelyn Ullrich, Ingrid Vasova, Matthias Wölfl, Robert Zeiser, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Stelios Kasikis, Nikolaos Katsivelos, Steven Kowalyk, George Morales, Rachel Young, Zachariah DeFilipp, James L.M. Ferrara, John E. Levine, Ryotaro Nakamura. Blood advances

A Day 14 Endpoint for Acute GVHD Clinical Trials. Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M. Al Malki, Francis Ayuk, Peter Bader, Janna Baez, Alexandra Capellini, Hannah Choe, Zachariah DeFilipp, Matthias Eder, Gilbert Eng, Aaron Etra, Sigrun Gleich, Stephan A. Grupp, Elizabeth Hexner, Matthias Hoepting, William J. Hogan, Stelios Kasikis, Nikolaos Katsivelos, Alina Khan, Carrie L. Kitko, Sabrina Kraus, Deukwoo Kwon, Pietro Merli, Joseph Portelli, Muna Qayed, Ran Reshef, Tal Schechter, Ingrid Vasova, Matthias Wölfl, Kitsada Wudhikarn, Rachel Young, Ernst Holler, Yi Bin Chen, Ryotaro Nakamura, John E. Levine, James L.M. Ferrara. Transplantation and Cellular Therapy

A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD. Muna Qayed, Urvi Kapoor, Scott Gillespie, Adrianna Westbrook, Paibel Aguayo-Hiraldo, Francis A. Ayuk, Mina Aziz, Janna Baez, Hannah Choe, Zachariah DeFilipp, Aaron Etra, Stephan A. Grupp, Elizabeth Hexner, Ernst Holler, William J. Hogan, Steven Kowalyk, Pietro Merli, George Morales, Ryotaro Nakamura, Michael A. Pulsipher, Tal Schechter, Jay Shah, Nikolaos Spyrou, Hrishikesh K. Srinagesh, Matthias Wölfl, Gregory Yanik, Rachel Young, Carrie L. Kitko, James L.M. Ferrara, John E. Levine. Transplantation and Cellular Therapy

View All Publications

Precision BMT Through Biomarkers

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ferrara during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Realta Life sciences
  • Reed Smith LLP
  • Allovir
  • Incyte Corporation
  • Bowman and Brooke
  • Bo Fu Rui
  • Medpace, Inc.
  • Physicians Education Research
  • Editas Medicine, Inc

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.